-
The Million Women Study reported a small increase in the incidence of ovarian cancer and ovarian cancer mortality in current users of postmenopausal hormone therapy.
-
Aspirin, Higher Doses No More Effective, Risky; Subclinical Hypothyroidism Treatment Benefits; FDA approvals
-
Codes and colleagues from France followed a cohort of 251 women with chronic hepatitis C, and report data associating the severity of fibrosis established by liver biopsies with menopause and hormone therapy.
-
Until recently, available information supported the notion that the transdermal route of administration of estradiol has less hepatic impact than the oral route.
-
-
In the May issue of the American Journal of Obstetrics and Gynecology, there was a report of a small randomized trial that might generate some cautious optimism regarding the treatment of PTL.
-
Human Papilloma Virus (HPV) is recognized worldwide as the principal culprit in the development of cervix cancer and its precursor dysplastic lesions. Also increasingly recognized is its role in other anogenital disease such as vulvar, vaginal and perianal warts, dysplasia and cancer.
-
Dietary Intervention for Fatty Liver Disease: Fat or Carbohydrate Restriction?; Motivational Interviewing to Enhance Weight Control in Diabetic Women; One-stop Shopping for Osteoporosis Treatment; Post-stroke prevention of venous thromboembolism; Chronic Kidney Disease: Treatment Modality and Quality of Life; Hepatitis C and Risk for Lymphoma
-
I am writing to provide important details from the Today contraceptive sponge worldwide Phase III clinical trial that were not presented in your recent article in Contraceptive Technology Update.
-
How can providers ease fears when it comes to vasectomy? Take a look at no-needle, no-scalpel vasectomy (NSV), which utilizes a jet injector to spray an anesthetic solution through the skin and around the vas prior to no-scalpel vasectomy.